Personal tools

MCL coexpression mm9:96: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 3: Line 3:
|coexpression_dpi_cluster_scores_median=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.554037262465759,0.570529552995427,0.725717751078804,0.744170496539592,0.616600292311791,0.327063587524422,0,0,0,0,0,0,0,0,0,0,0.442363997031626,0,0,0,0,0.16471887555933,0.114425913041783,0.0917293418104957,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0609639314262262,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0973736644748266,0.0788034163803455,0,0,0,0,0,0,0,0,0,0,0.0108143293845769,0,0,0,0.759157118832571,0.0670132089181356,0.143987900583469,0.226620625398645,0.375579469235657,0.576526785223497,0.819337039462749,0.897885793197887,0.92684030603843,1.13007137204767,1.36685186757635,1.33178657204587,1.3374581767418,0.998509988620871,0.921961733765906,0.963860511923835,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0711694759496908,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0857765460992942,0.147550511820338,0.437072053455101,0,0,0,0,0,0,0,0,0,0,0.143206333286023,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0945084131504676,0.0826465040380816,0.135986724295729,0.159715578577694,0.149856261570464,0.120876255993453,0.17765030293269,0.098117166361508,0.139013627015232,0.138165606837579,0.142877010563704,0.146762969796454,0.169172763866184,0.157304036833009,0.143482771193936,0.14986111676545,0.158843797677303,0.128033729919821,0.185379913858661,0.169342968499384,0.157166310227119,0.142355170205397,0.190168443418861,0.189990830607665,0.18359421108913,0.18842684556126,0.193442483447008,0.168656579551575,0.144268359582519,0.148982201447044,0.141863680480906,0.198305064902181,0,0.246299070429047,0.26939249630118,0,0.0865703124974023,0
|coexpression_dpi_cluster_scores_median=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.554037262465759,0.570529552995427,0.725717751078804,0.744170496539592,0.616600292311791,0.327063587524422,0,0,0,0,0,0,0,0,0,0,0.442363997031626,0,0,0,0,0.16471887555933,0.114425913041783,0.0917293418104957,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0609639314262262,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0973736644748266,0.0788034163803455,0,0,0,0,0,0,0,0,0,0,0.0108143293845769,0,0,0,0.759157118832571,0.0670132089181356,0.143987900583469,0.226620625398645,0.375579469235657,0.576526785223497,0.819337039462749,0.897885793197887,0.92684030603843,1.13007137204767,1.36685186757635,1.33178657204587,1.3374581767418,0.998509988620871,0.921961733765906,0.963860511923835,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0711694759496908,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0857765460992942,0.147550511820338,0.437072053455101,0,0,0,0,0,0,0,0,0,0,0.143206333286023,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0945084131504676,0.0826465040380816,0.135986724295729,0.159715578577694,0.149856261570464,0.120876255993453,0.17765030293269,0.098117166361508,0.139013627015232,0.138165606837579,0.142877010563704,0.146762969796454,0.169172763866184,0.157304036833009,0.143482771193936,0.14986111676545,0.158843797677303,0.128033729919821,0.185379913858661,0.169342968499384,0.157166310227119,0.142355170205397,0.190168443418861,0.189990830607665,0.18359421108913,0.18842684556126,0.193442483447008,0.168656579551575,0.144268359582519,0.148982201447044,0.141863680480906,0.198305064902181,0,0.246299070429047,0.26939249630118,0,0.0865703124974023,0
|gostat_on_MCL_coexpression=GO:0004866;endopeptidase inhibitor activity;2.98454489071577e-05;16426,11625,331535,16425,16644,20716!GO:0030414;protease inhibitor activity;2.98454489071577e-05;16426,11625,331535,16425,16644,20716!GO:0004857;enzyme inhibitor activity;0.000150380797304495;16426,11625,331535,16425,16644,20716!GO:0005615;extracellular space;0.00102927636994738;16841,208990,11625,16325,26464,14719,16426,622307,16425,16644,171284,77596,20716!GO:0030212;hyaluronan metabolic process;0.00118011381858165;16426,16425!GO:0044421;extracellular region part;0.00129215627208903;16841,208990,11625,16325,26464,14719,16426,622307,16425,16644,171284,77596,20716!GO:0004867;serine-type endopeptidase inhibitor activity;0.00133294705436289;16426,331535,16425,20716!GO:0006807;nitrogen compound metabolic process;0.0137854548160044;16426,14719,103149,16425,26464!GO:0042579;microbody;0.0137854548160044;93732,19301,74114!GO:0005777;peroxisome;0.0137854548160044;93732,19301,74114!GO:0006022;aminoglycan metabolic process;0.0137854548160044;16426,16425!GO:0030203;glycosaminoglycan metabolic process;0.0137854548160044;16426,16425!GO:0005743;mitochondrial inner membrane;0.0167685018473885;14719,27404,110446,71911!GO:0019866;organelle inner membrane;0.0179853258921231;14719,27404,110446,71911!GO:0031966;mitochondrial membrane;0.0183462511355603;14719,27404,110446,71911!GO:0044262;cellular carbohydrate metabolic process;0.0183462511355603;16426,16425,232493,19013!GO:0004869;cysteine protease inhibitor activity;0.0212996391249442;11625,16644!GO:0005740;mitochondrial envelope;0.0217406713638811;14719,27404,110446,71911!GO:0003805;coagulation factor XIa activity;0.0252299205133641;109821!GO:0008458;carnitine O-octanoyltransferase activity;0.0252299205133641;74114!GO:0016414;O-octanoyltransferase activity;0.0252299205133641;74114!GO:0033791;3alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoyl-CoA 24-hydroxylase activity;0.0252299205133641;93732!GO:0016415;octanoyltransferase activity;0.0252299205133641;74114!GO:0031090;organelle membrane;0.0275115187060926;14719,27404,110446,20440,71911!GO:0044429;mitochondrial part;0.0286262365326973;14719,27404,110446,71911!GO:0006631;fatty acid metabolic process;0.0346344415329955;93732,74114,19013!GO:0005975;carbohydrate metabolic process;0.0350631707253446;16426,16425,232493,19013!GO:0016811;hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides;0.0350631707253446;103149,26464!GO:0004069;aspartate transaminase activity;0.0350631707253446;14719!GO:0003837;beta-ureidopropionase activity;0.0350631707253446;103149!GO:0004373;glycogen (starch) synthase activity;0.0350631707253446;232493!GO:0003835;beta-galactoside alpha-2,6-sialyltransferase activity;0.0350631707253446;20440!GO:0003858;3-hydroxybutyrate dehydrogenase activity;0.0350631707253446;71911!GO:0007596;blood coagulation;0.0350631707253446;16644,109821!GO:0031975;envelope;0.0350631707253446;14719,27404,110446,71911!GO:0031967;organelle envelope;0.0350631707253446;14719,27404,110446,71911!GO:0007599;hemostasis;0.0350631707253446;16644,109821!GO:0050817;coagulation;0.0350631707253446;16644,109821!GO:0017000;antibiotic biosynthetic process;0.0434477343643651;!GO:0030502;negative regulation of bone mineralization;0.0434477343643651;11625!GO:0032787;monocarboxylic acid metabolic process;0.0488954984552584;93732,74114,19013!
|gostat_on_MCL_coexpression=GO:0004866;endopeptidase inhibitor activity;2.98454489071577e-05;16426,11625,331535,16425,16644,20716!GO:0030414;protease inhibitor activity;2.98454489071577e-05;16426,11625,331535,16425,16644,20716!GO:0004857;enzyme inhibitor activity;0.000150380797304495;16426,11625,331535,16425,16644,20716!GO:0005615;extracellular space;0.00102927636994738;16841,208990,11625,16325,26464,14719,16426,622307,16425,16644,171284,77596,20716!GO:0030212;hyaluronan metabolic process;0.00118011381858165;16426,16425!GO:0044421;extracellular region part;0.00129215627208903;16841,208990,11625,16325,26464,14719,16426,622307,16425,16644,171284,77596,20716!GO:0004867;serine-type endopeptidase inhibitor activity;0.00133294705436289;16426,331535,16425,20716!GO:0006807;nitrogen compound metabolic process;0.0137854548160044;16426,14719,103149,16425,26464!GO:0042579;microbody;0.0137854548160044;93732,19301,74114!GO:0005777;peroxisome;0.0137854548160044;93732,19301,74114!GO:0006022;aminoglycan metabolic process;0.0137854548160044;16426,16425!GO:0030203;glycosaminoglycan metabolic process;0.0137854548160044;16426,16425!GO:0005743;mitochondrial inner membrane;0.0167685018473885;14719,27404,110446,71911!GO:0019866;organelle inner membrane;0.0179853258921231;14719,27404,110446,71911!GO:0031966;mitochondrial membrane;0.0183462511355603;14719,27404,110446,71911!GO:0044262;cellular carbohydrate metabolic process;0.0183462511355603;16426,16425,232493,19013!GO:0004869;cysteine protease inhibitor activity;0.0212996391249442;11625,16644!GO:0005740;mitochondrial envelope;0.0217406713638811;14719,27404,110446,71911!GO:0003805;coagulation factor XIa activity;0.0252299205133641;109821!GO:0008458;carnitine O-octanoyltransferase activity;0.0252299205133641;74114!GO:0016414;O-octanoyltransferase activity;0.0252299205133641;74114!GO:0033791;3alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoyl-CoA 24-hydroxylase activity;0.0252299205133641;93732!GO:0016415;octanoyltransferase activity;0.0252299205133641;74114!GO:0031090;organelle membrane;0.0275115187060926;14719,27404,110446,20440,71911!GO:0044429;mitochondrial part;0.0286262365326973;14719,27404,110446,71911!GO:0006631;fatty acid metabolic process;0.0346344415329955;93732,74114,19013!GO:0005975;carbohydrate metabolic process;0.0350631707253446;16426,16425,232493,19013!GO:0016811;hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides;0.0350631707253446;103149,26464!GO:0004069;aspartate transaminase activity;0.0350631707253446;14719!GO:0003837;beta-ureidopropionase activity;0.0350631707253446;103149!GO:0004373;glycogen (starch) synthase activity;0.0350631707253446;232493!GO:0003835;beta-galactoside alpha-2,6-sialyltransferase activity;0.0350631707253446;20440!GO:0003858;3-hydroxybutyrate dehydrogenase activity;0.0350631707253446;71911!GO:0007596;blood coagulation;0.0350631707253446;16644,109821!GO:0031975;envelope;0.0350631707253446;14719,27404,110446,71911!GO:0031967;organelle envelope;0.0350631707253446;14719,27404,110446,71911!GO:0007599;hemostasis;0.0350631707253446;16644,109821!GO:0050817;coagulation;0.0350631707253446;16644,109821!GO:0017000;antibiotic biosynthetic process;0.0434477343643651;!GO:0030502;negative regulation of bone mineralization;0.0434477343643651;11625!GO:0032787;monocarboxylic acid metabolic process;0.0488954984552584;93732,74114,19013!
|ontology_enrichment_celltype=
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0002107!4.45e-28!22;UBERON:0007499!4.45e-28!22;UBERON:0006925!4.45e-28!22;UBERON:0009497!4.45e-28!22;UBERON:0000015!4.45e-28!22;UBERON:0002423!4.45e-28!22;UBERON:0006235!4.45e-28!22;UBERON:0008835!4.45e-28!22;UBERON:0003894!4.45e-28!22;UBERON:0004161!4.45e-28!22;UBERON:0008836!4.45e-28!22;UBERON:0009854!1.52e-26!23;UBERON:0009856!1.52e-26!23;UBERON:0002365!7.55e-24!25;UBERON:0002330!7.55e-24!25;UBERON:0005256!1.25e-13!45;UBERON:0005172!6.46e-13!49;UBERON:0005173!6.46e-13!49;UBERON:0002417!6.46e-13!49;UBERON:0000916!6.46e-13!49;UBERON:0003914!1.48e-09!47;UBERON:0003104!6.11e-09!61;UBERON:0009142!6.11e-09!61;UBERON:0002368!1.88e-08!60;UBERON:0009569!9.71e-08!66;UBERON:0002530!2.71e-07!65;UBERON:0003929!2.72e-07!55
}}
}}

Revision as of 21:31, 11 October 2012


Phase1 CAGE Peaks

 Short description
Mm9::chr10:126807606..126807617,-p2@Inhbc
Mm9::chr10:128356229..128356240,-p3@Rdh5
Mm9::chr10:128356246..128356283,-p2@Rdh5
Mm9::chr10:128356304..128356309,-p4@Rdh5
Mm9::chr10:23571233..23571259,+p2@Vnn3
Mm9::chr10:23571260..23571295,+p1@Vnn3
Mm9::chr10:23571301..23571313,+p3@Vnn3
Mm9::chr10:25256171..25256202,+p@chr10:25256171..25256202
+
Mm9::chr10:4922158..4922168,+p@chr10:4922158..4922168
+
Mm9::chr10:74869686..74869699,+p2@Upb1
Mm9::chr11:109857061..109857076,-p1@Abca8b
Mm9::chr11:110006907..110006918,+p@chr11:110006907..110006918
+
Mm9::chr11:110052090..110052091,-p@chr11:110052090..110052091
-
Mm9::chr11:120469806..120469816,+p2@Npb
Mm9::chr11:18785822..18785848,-p@chr11:18785822..18785848
-
Mm9::chr11:46512110..46512125,-p3@Timd2
Mm9::chr11:46512551..46512577,-p5@Timd2
Mm9::chr11:73140078..73140123,+p@chr11:73140078..73140123
+
Mm9::chr11:75027605..75027629,+p@chr11:75027605..75027629
+
Mm9::chr11:78314581..78314593,+p@chr11:78314581..78314593
+
Mm9::chr12:104789889..104789930,+p@chr12:104789889..104789930
+
Mm9::chr12:105644914..105644938,+p1@Serpina3n
Mm9::chr12:84765585..84765623,+p@chr12:84765585..84765623
+
Mm9::chr13:104827705..104827721,-p@chr13:104827705..104827721
-
Mm9::chr13:23928766..23928779,+p@chr13:23928766..23928779
+
Mm9::chr13:56649779..56649829,-p1@Lect2
Mm9::chr13:56649835..56649848,-p4@Lect2
Mm9::chr13:56649863..56649879,-p2@Lect2
Mm9::chr13:56649895..56649908,-p3@Lect2
Mm9::chr14:18617162..18617188,+p@chr14:18617162..18617188
+
Mm9::chr14:31736733..31736751,-p1@Itih3
Mm9::chr14:32450924..32450930,-p@chr14:32450924..32450930
-
Mm9::chr14:9091839..9091892,-p4@Acox2
Mm9::chr15:10922124..10922125,+p@chr15:10922124..10922125
+
Mm9::chr15:82523492..82523512,-p@chr15:82523492..82523512
-
Mm9::chr15:82523521..82523544,-p@chr15:82523521..82523544
-
Mm9::chr15:85602655..85602680,+p5@Ppara
Mm9::chr16:22887145..22887171,-p@chr16:22887145..22887171
-
Mm9::chr16:22892108..22892124,+p1@Ahsg
Mm9::chr16:22892205..22892222,-p@chr16:22892205..22892222
-
Mm9::chr16:22892296..22892368,-p@chr16:22892296..22892368
-
Mm9::chr16:22894423..22894465,-p1@uc007ysq.1
Mm9::chr16:22894496..22894514,-p2@uc007ysq.1
Mm9::chr16:22894903..22894934,-p3@uc007ysq.1
Mm9::chr16:22895286..22895297,-p@chr16:22895286..22895297
-
Mm9::chr16:22895330..22895339,-p@chr16:22895330..22895339
-
Mm9::chr16:22895349..22895357,-p@chr16:22895349..22895357
-
Mm9::chr16:22895364..22895405,-p@chr16:22895364..22895405
-
Mm9::chr16:22895407..22895419,-p@chr16:22895407..22895419
-
Mm9::chr16:22896630..22896639,-p@chr16:22896630..22896639
-
Mm9::chr16:22896641..22896672,-p@chr16:22896641..22896672
-
Mm9::chr16:22896674..22896687,-p@chr16:22896674..22896687
-
Mm9::chr16:22898249..22898262,-p@chr16:22898249..22898262
-
Mm9::chr16:22898268..22898294,-p@chr16:22898268..22898294
-
Mm9::chr16:22898891..22898925,-p@chr16:22898891..22898925
-
Mm9::chr16:22898930..22898948,-p@chr16:22898930..22898948
-
Mm9::chr16:22898959..22898971,-p@chr16:22898959..22898971
-
Mm9::chr16:22898981..22898988,-p@chr16:22898981..22898988
-
Mm9::chr16:22899004..22899025,-p@chr16:22899004..22899025
-
Mm9::chr16:22899043..22899048,-p@chr16:22899043..22899048
-
Mm9::chr16:22899125..22899148,-p@chr16:22899125..22899148
-
Mm9::chr16:22899207..22899232,-p@chr16:22899207..22899232
-
Mm9::chr16:22899292..22899312,-p@chr16:22899292..22899312
-
Mm9::chr16:22899321..22899330,-p@chr16:22899321..22899330
-
Mm9::chr16:23029085..23029099,-p3@Kng2
Mm9::chr16:23058399..23058424,+p1@Kng1
Mm9::chr16:23290537..23290607,+p4@St6gal1
Mm9::chr16:31422354..31422364,+p4@Bdh1
Mm9::chr16:31422374..31422394,+p3@Bdh1
Mm9::chr16:31422401..31422433,+p2@Bdh1
Mm9::chr16:35932815..35932826,-p@chr16:35932815..35932826
-
Mm9::chr16:5010163..5010218,-p@chr16:5010163..5010218
-
Mm9::chr17:28574977..28574992,-p@chr17:28574977..28574992
-
Mm9::chr17:28574995..28575006,-p@chr17:28574995..28575006
-
Mm9::chr17:43407289..43407315,+p1@Gpr110
Mm9::chr17:57361613..57361654,+p@chr17:57361613..57361654
+
Mm9::chr17:57364672..57364705,+p@chr17:57364672..57364705
+
Mm9::chr17:57366261..57366266,+p@chr17:57366261..57366266
+
Mm9::chr18:61879001..61879014,-p@chr18:61879001..61879014
-
Mm9::chr18:85041321..85041326,+p@chr18:85041321..85041326
+
Mm9::chr19:12674418..12674429,+p2@Gm4952
Mm9::chr19:36871574..36871584,-p@chr19:36871574..36871584
-
Mm9::chr19:8041088..8041091,-p@chr19:8041088..8041091
-
Mm9::chr1:174920446..174920468,+p@chr1:174920446..174920468
+
Mm9::chr1:191883202..191883204,+p@chr1:191883202..191883204
+
Mm9::chr1:71934490..71934502,+p4@Gm8883
Mm9::chr1:71934548..71934577,+p3@Gm8883
Mm9::chr2:10052202..10052213,-p2@Itih2
Mm9::chr2:10052265..10052316,-p1@Itih2
Mm9::chr3:132477952..132477963,+p@chr3:132477952..132477963
+
Mm9::chr3:142394491..142394495,+p@chr3:142394491..142394495
+
Mm9::chr3:57191661..57191672,-p@chr3:57191661..57191672
-
Mm9::chr3:82835024..82835045,-p@chr3:82835024..82835045
-
Mm9::chr4:15076902..15076920,-p8@Necab1
Mm9::chr4:87527641..87527666,-p@chr4:87527641..87527666
-
Mm9::chr5:105775498..105775508,-p1@Gbp11
Mm9::chr5:110715178..110715196,-p2@Pxmp2
Mm9::chr5:122469404..122469438,-p@chr5:122469404..122469438
-
Mm9::chr5:146617438..146617452,-p1@Cyp3a44
Mm9::chr5:8995739..8995744,-p@chr5:8995739..8995744
-
Mm9::chr5:8996998..8997038,-p7@Crot
Mm9::chr5:8997089..8997093,-p8@Crot
Mm9::chr5:90904325..90904362,-p@chr5:90904325..90904362
-
Mm9::chr5:90990090..90990104,+p1@5830473C10Rik
Mm9::chr6:117562580..117562597,-p@chr6:117562580..117562597
-
Mm9::chr6:128473980..128474019,+p@chr6:128473980..128474019
+
Mm9::chr6:129347326..129347350,+p2@Clec1b
Mm9::chr6:142421595..142421635,-p1@Gys2
Mm9::chr6:51631940..51631943,-p@chr6:51631940..51631943
-
Mm9::chr6:57485404..57485415,-p5@Ppm1k
Mm9::chr7:141214497..141214517,+p@chr7:141214497..141214517
+
Mm9::chr7:28037194..28037227,+p2@Adck4
Mm9::chr7:28037275..28037285,+p5@Adck4
Mm9::chr8:106635288..106635301,+p@chr8:106635288..106635301
+
Mm9::chr8:106635312..106635332,+p@chr8:106635312..106635332
+
Mm9::chr8:106635339..106635357,+p@chr8:106635339..106635357
+
Mm9::chr8:10899915..10899928,+p1@uc009kuw.1
p1@uc009kux.1
Mm9::chr8:11071465..11071479,+p@chr8:11071465..11071479
+
Mm9::chr8:112099680..112099697,+p@chr8:112099680..112099697
+
Mm9::chr8:41977607..41977634,+p@chr8:41977607..41977634
+
Mm9::chr8:42300500..42300522,-p1@Fgl1
Mm9::chr8:46347330..46347350,-p1@F11
Mm9::chr8:46347356..46347363,-p4@F11
Mm9::chr8:46347366..46347411,-p2@F11
Mm9::chr8:46366955..46366973,-p@chr8:46366955..46366973
-
Mm9::chr8:98412410..98412420,-p3@Got2
Mm9::chr9:103119689..103119718,+p@chr9:103119689..103119718
+
Mm9::chr9:103122168..103122192,+p@chr9:103122168..103122192
+
Mm9::chr9:103125339..103125368,+p@chr9:103125339..103125368
+
Mm9::chr9:110893074..110893103,-p@chr9:110893074..110893103
-
Mm9::chr9:53418390..53418433,-p2@Acat1
Mm9::chrX:135619750..135619764,-p1@Serpina7
Mm9::chrX:135619769..135619786,-p2@Serpina7
Mm9::chrX:156943111..156943114,+p@chrX:156943111..156943114
+


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data

GO IDGO nameFDR corrected p-value
GO:0004866endopeptidase inhibitor activity2.98454489071577e-05
GO:0030414protease inhibitor activity2.98454489071577e-05
GO:0004857enzyme inhibitor activity0.000150380797304495
GO:0005615extracellular space0.00102927636994738
GO:0030212hyaluronan metabolic process0.00118011381858165
GO:0044421extracellular region part0.00129215627208903
GO:0004867serine-type endopeptidase inhibitor activity0.00133294705436289
GO:0006807nitrogen compound metabolic process0.0137854548160044
GO:0042579microbody0.0137854548160044
GO:0005777peroxisome0.0137854548160044
GO:0006022aminoglycan metabolic process0.0137854548160044
GO:0030203glycosaminoglycan metabolic process0.0137854548160044
GO:0005743mitochondrial inner membrane0.0167685018473885
GO:0019866organelle inner membrane0.0179853258921231
GO:0031966mitochondrial membrane0.0183462511355603
GO:0044262cellular carbohydrate metabolic process0.0183462511355603
GO:0004869cysteine protease inhibitor activity0.0212996391249442
GO:0005740mitochondrial envelope0.0217406713638811
GO:0003805coagulation factor XIa activity0.0252299205133641
GO:0008458carnitine O-octanoyltransferase activity0.0252299205133641
GO:0016414O-octanoyltransferase activity0.0252299205133641
GO:00337913alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoyl-CoA 24-hydroxylase activity0.0252299205133641
GO:0016415octanoyltransferase activity0.0252299205133641
GO:0031090organelle membrane0.0275115187060926
GO:0044429mitochondrial part0.0286262365326973
GO:0006631fatty acid metabolic process0.0346344415329955
GO:0005975carbohydrate metabolic process0.0350631707253446
GO:0016811hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides0.0350631707253446
GO:0004069aspartate transaminase activity0.0350631707253446
GO:0003837beta-ureidopropionase activity0.0350631707253446
GO:0004373glycogen (starch) synthase activity0.0350631707253446
GO:0003835beta-galactoside alpha-2,6-sialyltransferase activity0.0350631707253446
GO:00038583-hydroxybutyrate dehydrogenase activity0.0350631707253446
GO:0007596blood coagulation0.0350631707253446
GO:0031975envelope0.0350631707253446
GO:0031967organelle envelope0.0350631707253446
GO:0007599hemostasis0.0350631707253446
GO:0050817coagulation0.0350631707253446
GO:0017000antibiotic biosynthetic process0.0434477343643651
GO:0030502negative regulation of bone mineralization0.0434477343643651
GO:0032787monocarboxylic acid metabolic process0.0488954984552584



Relative expression of the co-expression cluster over median <br>Analyst:




Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br><br>uberon_data<br><br>

Uber Anatomy
Ontology termp-valuen
liver4.45e-2822
epithelial sac4.45e-2822
digestive gland4.45e-2822
epithelium of foregut-midgut junction4.45e-2822
anatomical boundary4.45e-2822
hepatobiliary system4.45e-2822
foregut-midgut junction4.45e-2822
hepatic diverticulum4.45e-2822
liver primordium4.45e-2822
septum transversum4.45e-2822
liver bud4.45e-2822
digestive tract diverticulum1.52e-2623
sac1.52e-2623
exocrine gland7.55e-2425
exocrine system7.55e-2425
trunk mesenchyme1.25e-1345
abdomen element6.46e-1349
abdominal segment element6.46e-1349
abdominal segment of trunk6.46e-1349
abdomen6.46e-1349
epithelial tube1.48e-0947
mesenchyme6.11e-0961
entire embryonic mesenchyme6.11e-0961
endocrine gland1.88e-0860
subdivision of trunk9.71e-0866
gland2.71e-0765
gut epithelium2.72e-0755


TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data

Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}

Retrieved from "http://f5-webapp4.gsc.riken.jp/resource_browser/index.php?title=MCL_coexpression_mm9:96&oldid=2156790"